Newsroom | 9852 results

SAINT PAUL, Minn.--(BUSINESS WIRE)--The Emily Program announced a free public webinar, Up Close with Jessie Diggins, who speaks openly about her recovery from an eating disorder....

MANHASSET, N.Y.--(BUSINESS WIRE)--In recognition of their impact on society through the successful production, patenting and commercialization of groundbreaking technologies, four esteemed scientists from Northwell Health’s Feinstein Institutes for Medical Research – Lior Brimberg, PhD; Jared M. Huston, MD; Stavros Zanos, MD, PhD; and Theodoros Zanos, PhD – have been named to the prestigious 2026 class of Senior Members by the National Academy of Inventors (NAI). This significant recognition hi...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today reported its full-year 2025 financial results and provided business updates. “We are proud of the strong execution and momentum across our organization, following a year of significant progress in our comprehensive development program...

SAN MATEO, Calif.--(BUSINESS WIRE)--Salma Health launches integrated brain health center of excellence, ushering in a new era for comprehensive brain care, technology, and research...

DALLAS--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, today announced its board-certified psychiatrists and psychiatric mental health nurse practitioners are ready to see new patients at its clinics in Frisco, Las Colinas, Fort Worth, Southlake, Arlington, and University Park. Serenity providers prioritize full-spectrum mental health services tailored to each patient’s needs. Treatments include...

NEW YORK--(BUSINESS WIRE)--Dr. Ainsley MacLean, MD, FACR, will advise Brellium as the company develops AI powered compliance solutions that both providers and payers rely on....

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were issued on January 13, 2025, for proceeds of approximately $200 million. Upon exercise of these outstanding warrants, Compass Pathways is issuing 15,160,619 American Depositary Shares (“ADSs”) and in lieu of ADSs, to certain institutional investors, pre-funded warrant...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2025. “Acadia closed 2025 with another strong quarter, capping a milestone year in which we surpassed $1 billion in annual revenue for the first time,” said Catherine Owen Adams, Chief Executive Officer. “NUPLAZID had another strong quarter driven by underlying volume growth, reflecting continued momentum in the business. In the fo...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, will present at the 46th Annual TD Cowen Healthcare Conference. Vistagen’s President and Chief Executive Officer, Shawn Singh, will present a corporate overview on Monday, March 2, 2026, at 3:50 p.m. Eastern Time. A replay of the w...

WATERTOWN, Mass.--(BUSINESS WIRE)--Ahead of Rare Disease Day 2026, data from Konovo show significant gaps by US, EU5 doctors in meeting the mental health needs of rare disease patients....